CANANDAIGUA NATIONAL CORP

Position in GILD — Gilead Sciences, Inc.

CIK 759458 CANANDAIGUA, NY

Position in GILD

as of Mar 31, 2026 · filed Apr 8, 2026 Compact

Position Value

$757,894

-$59,913 QoQ

Shares Held

5,438

-42.9% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

CANANDAIGUA NATIONAL CORP holds $55,829,606 across 9 Drug Manufacturers - General names. GILD ranks #8 (1.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	86,448	$21,131,349
2	MRK	Merck & Co., Inc.	86,888	$10,451,757
3	LLY	ELI LILLY & Co	7,956	$7,317,690
4	ABBV	AbbVie Inc.	27,988	$6,087,110
5	PFE	Pfizer Inc	159,496	$4,478,647
6	AMGN	Amgen Inc	10,827	$3,809,479
7	BMY	Bristol Myers Squibb Co	24,182	$1,466,638
8	GILD	Gilead Sciences, Inc. This page	5,438	$757,894

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$757,894	5,438	-42.9%	Shares	Sole	2026-04-08
2022-12-31	$817,807	9,526	+1.4%	Shares	Sole	2023-01-25
2022-09-30	$579,700	9,397	-0.9%	Shares	Sole	2022-10-05
2022-06-30	$586,391	9,487	-11.1%	Shares	Sole	2022-07-05
2022-03-31	$634,509	10,673	-1.0%	Shares	Sole	2022-05-09
2021-12-31	$783,171	10,786	-5.0%	Shares	Sole	2022-01-04
2021-09-30	$792,867	11,351	-3.4%	Shares	Sole	2021-10-04
2021-06-30	$809,518	11,756	-0.7%	Shares	Sole	2021-07-06
2021-03-31	$765,413	11,843	-0.2%	Shares	Sole	2021-04-05
2020-12-31	$691,371	11,867	-3.1%	Shares	Sole	2021-02-11
2020-09-30	$774,140	12,251	+0.1%	Shares	Sole	2020-10-19
2020-06-30	$941,437	12,236	—	Shares	Sole	2020-07-07
No filing history on record for this holder in this stock.